Removing the Vertebrate-Specific TBP N Terminus Disrupts Placental β2m-Dependent Interactions with the Maternal Immune System  by Hobbs, Nicole K. et al.
Cell, Vol. 110, 43–54, July 12, 2002, Copyright 2002 by Cell Press
Removing the Vertebrate-Specific TBP N Terminus
Disrupts Placental 2m-Dependent Interactions
with the Maternal Immune System
1997). Most of the effects characterized to date are
governed by placental (zygote-derived) gene expression
rather than by maternal gene expression. For example,
placental trophoblasts produce a number of locally im-
munosupressive molecules, including progesterone, in-
Nicole K. Hobbs,1 Alla A. Bondareva,1
Sheila Barnett,2 Mario R. Capecchi,2
and Edward E. Schmidt1,3
1Veterinary Molecular Biology
Marsh Laboratories
doleamine 2,3-dioxegenase, metal proteases, and inhib-Montana State University
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1998; Van Vlasselaer and Vandeputte, 1984; Xu et al.,2 Howard Hughes Medical Institute
2000). Genetic disruption of some of these functions inEccles Institute of Human Genetics
mice leads to spontaneous abortion (Xu et al., 2000;University of Utah
Yamamoto et al., 1998). Also, trophoblasts at the placen-Salt Lake City, Utah 84112
tal/maternal interface in humans express the placenta-
specific nonclassical MHC-I heavy-chain genes HLA-E
and HLA-G. Immune-mediated spontaneous abortionsSummary
often are correlated with failure to express these genes,
suggesting that these nonclassical MHC-I genes mayMammalian TBP consists of a 180 amino acid core that
play a role in preventing rejection of the placenta (Fuzziis common to all eukaryotes, fused to a vertebrate-
et al., 2002; Hutter et al., 1998; Loke and King, 2000;specific N-terminal domain. We generated mice hav-
Pfeiffer et al., 2001; Riteau et al., 2001). Mechanistically,ing a modified tbp allele, tbpN, that produces a version
little is known about the gene regulation systems that theof TBP lacking 111 of the 135 vertebrate-specific
placenta uses to evade a maternal rejection response oramino acids. Most tbpN/N fetuses (90%) died in mid-
whether these systems might be useful for protectinggestation from an apparent defect in the placenta.
other foreign tissue grafts from rejection.tbpN/N fetuses could be rescued by supplying them
We are interested in understanding how the basalwith a wild-type tetraploid placenta. Mutants also
transcription machinery has been specialized for ad-could be rescued by rearing them in immunocom-
vanced gene regulation in complex multicellular organ-promised mothers. In immune-competent mothers,
isms. Whereas Archaebacteria use only a single RNAsurvival of tbpN/N fetuses increased when fetal/pla-
polymerase to transcribe mRNA, rRNA, and tRNAcental 2m expression was genetically disrupted.
(Hausner and Thomm, 2001), eukaryotes evolved threeThese results suggest that the TBP N terminus func-
specialized RNA polymerases to perform these func-tions in transcriptional regulation of a placental 2m-
tions. The TATA binding protein (TBP) is used for pro-dependent process that favors maternal immunotoler-
moter recognition during transcription initiation by all ofance of pregnancy.
these RNA polymerases in archaea and in eukaryotes.
TBP has a 180 amino acid core that is almost perfectlyIntroduction
conserved in all species (Hernandez, 1993). That eukary-
otic TBP and Archaebacteria TBP evolved from a com-Female eutherian (placental) mammals face an odd co-
mon ancestor can be inferred by the conserved function,nundrum. On one hand, mammals have the most ad-
the high degree of amino acid similarity, and the nearlyvanced defense system against pathogenic insults—the
superimposable crystal structures for TBP from eachadaptive immune system. This system functions, in part,
superkingdom (Littlefield et al., 1999). Indeed, between
on the principle of continuous surveillance for presenta-
archaea and man, TBP has been more highly conserved
tion of correct “self” antigens by the major histocompati-
by natural selection than even RNA polymerase!
bility complex-I (MHC-I) surface proteins. Surfaces that Phylogenetic differences in organism complexity cor-
present foreign antigens are generally attacked and de- relate not only to the appearance of new families of
stroyed (Pamer and Cresswell, 1998). On the other hand, structural genes, but also to new families of regulators—
the female eutherian’s immune system must tolerate a transcription factors, mediators, chromatin-modifying
large and decidedly foreign body, the fetus/placenta proteins, etc.—to control these new genes in their ever
(Erlebacher, 2001; Wegmann, 1980). more complex and demanding environments. Concomi-
The mechanisms by which tolerance of the placenta tantly, the role of TBP became more complex. Unlike in
occurs are not yet entirely clear (Erlebacher, 2001; Loke archaea, where TBP may function as a single-subunit
and King, 2000). Although pregnancy sensitizes the entity (Qureshi et al., 1997), in lower eukaryotes TBP
mother to paternal antigens (van Kampen et al., 2001), it assembles into three multisubunit factors, SL1, TFIID,
has only relatively small systemic effects on the mother’s and TFIIIB, of which TBP is, by mass, only a minor
immune competence (Tafuri et al., 1995), and priming component of each (Hernandez, 1993). SL1 is a part of
the mother with paternal or fetal antigens has no effect the complex that directs transcription of the rRNA genes
on pregnancy (Wegmann et al., 1979). Rather, tolerance by RNA Pol I; TFIID functions during mRNA transcription
stems mostly from local effects at the maternal/placen- initiation by RNA Pol II; and TFIIIB functions in the initia-
tal interface (Cross et al., 1994; Rinkenberger et al., tion of transcription of tRNAs and some other small
RNAs by RNA Pol III. In mammals, TBP interacts with
at least one other multiprotein factor, SNAPc, which is in3 Correspondence: eschmidt@montana.edu
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Figure 1. Targeted Mutagenesis of N-Terminal Protein-Coding Sequences of the Mouse tbp Gene
(A) Targeting strategy and targeting vector design. The 5 end of the wild-type mouse tbp gene (tbp) is diagramed (fine horizontal line on
top) indicating 5 exons (thickened regions of line, labeled 1C, 1D, and 1E for alternate promoter/first exons [Ohbayashi et al., 1996; Schmidt
et al., 1997], 2, 3, and 4), selected restriction sites (b, Bam HI; e, Eco RI; s, Sac I; x, Xho I), diagnostic PCR primers (arrows), and PCR product
sizes (region between arrows, lengths indicated). Below is indicated the predominant splicing pattern (gray broken lines [Schmidt et al., 1997])
that yields the predominant TBP mRNA (yellow) and cognate TBP protein product (blue box). Translation initiates in the second exon and
terminates in the eighth exon (Sumita et al., 1993). The N and C termini are indicated. Below is shown the targeting vector design, including
the replacement of most of exon 3 with two tandem copies of the FLAG epitope tag (green box). Below this is indicated the targeted tbp
allele still containing the loxP-flanked MC1p-neo gene, with the sizes of diagnostic PCR fragments from the primers shown above on the tbp
allele indicated. At the bottom is shown the targeted allele after removal of the loxP-flanked MC1p-neo gene by Cre recombinase, with the
resultant expressed somatic cell TBP mRNA and TBP protein indicated below.
(B) Genotyping animals using the primer set that spans the N mutation.
(C) Expression of TBP and TBP-N mRNA in mouse cells and tissues. RNase protection assays were performed on 10 g of total RNA from
the indicated tissues harvested from adult male mice (8- to 12-weeks-old) of the indicated genotypes, supplemented with yeast RNA to 50
g (see Supplemental Data at http://www.cell.com/cgi/content/full/110/1/43/DC1). Positions of undigested probe, TBP mRNA, and TBP-N
mRNA are indicated at right. Abbreviations: P, 1:100 dilution of undigested probe; C, control lane containing probe hybridized to 50 g yeast
RNA; T, testis; K, kidney; S, spleen; L, liver; and B, brain.
(D) Wild-type and mutant (N) TBP protein expression in adult mouse spleen nuclei (right).
the complex that directs the production of small nuclear protein produced would lack most of the vertebrate-
specific TBP N terminus. This mutation did not disruptRNAs (snRNAs) by either Pol II or Pol III (Hernandez,
1993). basal transcription functions or basal cell physiology.
Rather, mouse cells and embryos bearing this mutationIn addition to the 180 amino acid core, TBP acquired
a large N-terminal domain in an ancestor to tetrapod were normal by nearly all parameters, and the embryos
could, occasionally, develop into adult mice. Impor-vertebrates (Hashimoto et al., 1992). This novel domain
represents yet another complexity added to the basal tantly, however, most mutants died in midgestation from
a placental defect. These mutant fetuses could be res-transcription machinery during evolution. We hypothe-
sized that the TBP N terminus might play a role in verte- cued by supplying them with a wild-type placenta.
In this paper, we show that most tbpN/N fetuses sur-brate-specific gene regulation. To test this, we designed
a mutant allele of the mouse tbp gene that we expected vive midgestation in severely immune-compromised
mothers. Moreover, in immune-competent mothers,to exhibit normal TBP protein expression, but the TBP
The TBP N Terminus
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Table 1. Survival to Weaning
/ N/ N/N (n)
(N/)  (N/) matings 141 (100%) 197 (69.9%) 4 (2.8%) 342 (p  0.001)a
(N/N)  (N/) matings – 68 (70%)b 3 (3.1%)b 71 (p  0.001)a
Numbers of animals surviving to weaning for 67 litters from heterozygous intercrosses and 11 litters from matings of homozygous mutant
males to heterozygous females are indicated. Numbers in parentheses indicate the percent survival of animals of each genotype based on
Mendelian ratios of fertilized eggs and 100% survival of wild-type animals, which is valid because litters of pups harvested at 7.5 to 9.5 d.p.c.
exhibited Mendelian ratios of all three genotypes (see text).
a Chi-square test that survival differs from Mendelian genotype ratios,  	 0.05.
b Since matings with homozygous mutant males cannot yield wild-type animals, we assumed that heterozygous pups of these matings, like
in the matings of heterozygous parents above, yielded 70% survival. Thus, based on survival of 68 N/ pups, we calculated that 96 zygotes
each of N/ and N/N existed, and homozygous percent survival was derived from this.
tbpN/N fetuses are much more likely to survive midges- as they did wild-type embryos (Table 2). Thus, the TBP-
N mutation caused lethality with 22% penetrance intation if they also lack 
2-microglobulin (
2m). Our data
support the hypothesis that the TBP N terminus is an the heterozygous state and 91% penetrance in the ho-
mozygous state between 10.5 and 12.5 days of gesta-essential component in a signaling pathway that regu-
tion. No additional loss was detected during gestation;lates a placenta-specific 
2m-dependent process. This,
however, there was a 67% loss of the remaining homozy-in turn, may be a part of the mechanism that placentas
gous animals between 17.5 days of gestation anduse to evade a maternal rejection response.
weaning.
Surviving homozygous mutant mice of both genders
were healthy and fertile; however, they exhibited no in-Results
creased incidence of rearing homozygous mutant pups
(Table 1). This indicated that their survival did not resultDesign and Production of Mice Bearing
from a heritable genetic trait. Moreover, since we havethe tbpN Allele
now had several homozygous mutant animals born toIn previous studies, we had mapped the promoters and
homozygous mutant mothers, we can exclude the possi-first exons of the mouse tbp gene (Ohbayashi et al.,
bility that the wild-type tbp allele of heterozygous moth-1996; Schmidt et al., 1997). This information was used
ers rescued the surviving homozygous pups in trans.to design a targeting vector that would replace the en-
dogenous gene with a mutant version that was as similar
to the original gene as possible except that the protein Development of tbpN/ and tbpN/N
produced would lack amino acids 25–135 of the verte- Mouse Fetuses
brate-specific N terminus (Figure 1A). RNase protection Most mutant fetuses died between 10.5 and 12.5 days
analyses showed that expression of the tbpN allele of gestation; however, all systems, organs, tissues, and
quantitatively matched that of the wild-type tbp allele cell types appeared to be intact and functioning prior
(Figure 1C). The first 24 amino acids were retained to to death (Figures 2A and 2B). The heart was beating,
preserve the relative turnover rate of the mutant protein embryonic blood cells appeared normal and were circu-
lating to the most distal small capillaries, and there were(Varshavsky, 1997) such that accumulation of the mutant
no signs of hemorrhage. The only apparent defect inprotein would match that of wild-type TBP. Western
mutant embryos was that they often, but not always,blotting analyses confirmed that steady-state accumu-
exhibited various degrees of developmental retardationlation of TBP-N protein matched that of wild-type TBP
(Figure 2A). Nevertheless, the embryos appeared normal(Figure 1D).
for their “somite-count” stage (Hogan et al., 1994).
Survival of tbpN/ and tbpN/N Mice and Embryos Defects in tbpN/N Placentas
Intercrosses between heterozygous animals yielded Because we could not find defects in the embryos that
140% as many heterozygous pups and 2.8% as many accounted for loss of the homozygous mutants, atten-
homozygous mutant pups as they did wild-type pups tion was focused on the placenta. If primary failure was
that survived to weaning (Table 1). This indicated that due to placental defects, these defects should precede
the tbpN allele was recessive lethal, causing 97% loss of embryonic pathology or death. Embryos and placentas
homozygous mutants, and slightly haploid-insufficient, were harvested 10.5 and 11.5 days after mating hetero-
resulting in 30% loss of heterozygotes. zygous parents. To avoid confusing secondary patho-
Litters harvested between 7.5 and 9.5 days postfertil- logical consequences as putative primary defects, the
ization (d.p.f.) exhibited Mendelian ratios of all three placentas of embryos that were already dead or re-
genotypes. Between 10.5 and 12.5 d.p.f., numerous em- sorbing were excluded from analyses. Of the remaining
bryos were found dying and resorbing, and numbers of N/N placentas, many showed no overt defects, likely
recoverable homozygous mutant embryos decreased. because the pathology had not yet progressed to a point
Litters harvested between 13.5 and 17.5 d.p.f. con- that we could detect. However, in about 25% of the
tained, on average, 157% as many heterozygous em- placentas, regions could be found in which embryonic
and maternal blood were mixing, and clots of maternalbryos, and 8.7% as many homozygous mutant embryos,
Cell
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Table 2. Fetal Rescue by Wild-Type Tetraploid Placentas
/ N/ N//N (n)
(N/)  (N/) matings 23 (100%) 36 (78.3%) 2 (8.7%) 61 (p  0.001)a
(N/)  (N/) 2N fetuses on 7 (100%) 15 (107%) 8 (114%) 30 (p  0.001)b
(/)  (/) 4N placentas
Numbers of fetuses surviving to 15.5 d.p.f. for natural matings between heterozygous animals (7 pregnancies) and for chimeras of diploid
morulae of natural matings between heterozygous animals fused to tetraploid morulae from wild-type matings implanted into wild-type
surrogate mothers (5 pregnancies). Numbers in parentheses indicate the relative percent survival of animals of each genotype calculated as
in Table 1.
a Chi-square analysis of difference from Mendelian 1:2:1 ratio,  	 0.05.
b Chi-square analysis of rescue compared to (N/)  (N/) matings above,  	 0.05. The ratio of genotypes for the fetuses on wildtype
tetraploid placentas (7:15:8) does not differ significantly from a Mendelian 1:2:1 ratio ( 	 0.05, p  0.1), which is consistent with complete
rescue.
blood were abundant (Figure 2C). Also, although tro- the placenta, were composed primarily of tetraploid
wild-type cells. Results showed Mendelian ratios of fe-phoblast giant cells are normally phagocytic and occa-
sionally contain hemophagic vesicles, many N/N tuses of all three genotypes (Table 2). We conclude that
the primary defect of removing the N terminus of TBPplacentas exhibited evidence of far more extensive he-
mophagocytosis (Figure 2D). in mice is disruption of a situation-specific function,
which is required in early postimplantation placentas,The histopathology suggested that the primary defect
of our mutation might be placental. To test this empiri- but not in fetuses.
cally, we used diploid/tetraploid embryo chimeras (Guil-
lemot et al., 1994; Hogan et al., 1994; Nagy et al., 1990) Survival of tbpN/N Fetuses in
Immunocompromised Mothersto generate mice where the embryo proper was derived
primarily of diploid cells from crosses between tbpN/ Rag1 knockout (rag1/) mice lack mature B and T cells,
leaving them without adaptive immunity (Mombaerts etparents, whereas the extraembryonic tissues, including
Figure 2. Histopathology of tbpN/N Fetuses and Placentas
(A) Wild-type (/) and homozygous mutant (N/N) 10.5 d.p.f. whole fetuses from the same litter.
(B) Histology of 10.5 d.p.f. N/N fetus.
(C) Evidence of hemorrhage in placenta, showing a blood sinus with a large clot of maternal blood associated with peripheral polymorphonuclear
leukocytes, as well as mixing of maternal and embryonic blood.
(D) Trophoblast giant cells form normally and have normal, large, polyploid nuclei; however, they are engorged with heme-filled vesicles,
which suggests that the giant cells in mutant placentas are particularly active in hemophagocytosis.
Abbreviations: ba, brachial arch; cl, clot; da, dorsal aorta; eRBC, embryonic red blood cells; fb, forebrain; g, gut; gcn, giant cell nucleus; h,
heart; hv, hemophagic vesicles; li, liver; mRBC, maternal red blood cell; nt, neural tube; s, somite; and uc, umbilical cord.
The TBP N Terminus
47
Table 3. Fetal Rescue Past Midgestation
Fetal Survival as a Function of Maternal rag1 Genotypea
Parental Genotypes (Paternal  Maternal) / N/ N/N n (litters [av. size])
tbpN/;rag1/  tbpN/;rag1/ 9 20 (111%) 9 (100%) 38b (p  0.001)c (6 [6.3])
tbpN/N;rag1/  tbpN/;rag1/ – 15 13 (87%) 28b (5 [5.6])
tbpN/;rag1/  tbpN/;rag1/ 23 36 (78%) 2 (8.7%) 61d (9 [6.8])
Fetal Survival as a Function of Fetal 
2m Genotypee
Fetal Genotype / N/ N/N n

2m/ 25 42 (84%) 2 (8%) 69

2m/ 29 55 (95%) 14 (48%) 98 (p  0.001)f
a For matings with tbpN/ fathers, we assumed 100% survival of tbp/ fetuses to estimate percent survival; for matings with tbpN/N fathers,
we assumed 100% survival of heterozygous fetuses.
b All fetuses rag1/.
c Chi-square test that genotype ratio differs significantly from tbpN/;rag1/  tbpN/;rag1/ mating shown below, as a measure of rescue,
 	 0.05.
d All fetuses rag1/.
e To ensure that all animals had an equivalent immune-competent maternal environment, all litters were from tbpN/;
2m/ females mated
with males which were tbpN/;
2m/; tbpN/;
2m/; or tbpN/;
2m/. Fetuses were genotyped for both tbp and for 
2m, and data are
segregated based on the fetal 
2m genotype.
f Chi-square test that tbp genotype ratios of 
2m/ fetuses are significantly different from those of 
2m/ fetuses,  	 0.05.
al., 1992). We asked whether the rag1 mutation in moth- tas involves failure of a 
2m-dependent process that
can be genetically rescued by obliterating placental
2mers could genetically complement the tbpN/N condition
in the fetus/placenta. Mice bearing the tbpN mutation expression.
were crossed into the Rag1 knockout line to obtain fe-
males that were tbpN/;rag1/. These females were Rejection of tbpN/N Placentas Is
a Local Responseused in timed matings with tbpN/;rag1/ males or with
tbpN/N;rag1/ males such that all zygotes would be We wished to determine whether those homozygous
embryos that survived in immune-competent mothersrag1/. Results showed that roughly 92% of the tbpN/N
fetuses in these matings survived the midgestational did so because particular mothers were more tolerant
of the mutants (i.e., maternal determinants), or becauseblock (Table 3). Similar results were found when the
tbpN mutation was bred into SCID mice (see Supple- particular tbpN/N placentas failed to “trigger” the rejec-
tion response (i.e., placental determinants). We hypothe-mental Data at http://www.cell.com/cgi/content/full/
110/1/43/DC1). Since survival could be achieved by al- sized that if maternal determinants allowed tolerance of
tbpN/N placentas, then in those pregnancies, all tbpN/Ntering the maternal environment, it is unlikely that tbpN/
N placentas were intrinsically unable to support a fetus, fetuses should survive. Conversely, if placental determi-
nants were responsible for survival, then it should bebut rather they interacted inappropriately with immune-
competent mothers. Thus, death of tbpN/N fetuses in possible to find surviving tbpN/N fetuses in pregnancies
in which other tbpN/N fetus were being rejected. Toimmune-competent mothers resulted, at least in part,
from a placental defect that led to maternal rejection. address this, we set up tbpN/  tbpN/ matings and
examined the genotype ratios and numbers of resorbing
fetuses in mothers in which one or more tbpN/N fetusesGenetic Rescue of tbpN/N Fetuses by Disruption
of Fetal/Placental 2m Expression survived past midgestation. From six pregnancies we
found only one in which no fetuses were being resorbed,The role of the maternal immune system in failure of
tbpN/N fetuses led us to hypothesize that the defect only one litter in which more than one tbpN/N fetus
survived midgestation, and, overall, sub-Mendelian rep-involved inappropriate antigen presentation. Most
MHC-I/MHC-I-like heavy chains require the common resentation of tbpN/N fetuses (Table 4). Moreover, our
colony has had two successful pregnancies from mat-light chain, 
2m, for assembly and subsequent surface
presentation (Margulies, 1999; Pamer and Cresswell, ings of tbpN/N males with tbpN/N females, in which all
zygotes would be tbpN/N (see Supplemental Data at1998). Thus, if rejection of the tbpN/N fetuses involved
MHC-I or MHC-I-like molecules, then the defect should http://www.cell.com/cgi/content/full/110/1/43/DC1).
These two pregnancies led to only three surviving pups,be complemented by the 
2m knockout (Koller et al.,
1990). The tbpN mutation was crossed into the 
2m although in matings with wild-type animals, both tbpN/N
males and tbpN/N females showed normal litter sizesknockout line to obtain tbpN/;
2m/ females. These
females were bred with males that were tbpN/;
2m/, (data not shown), indicating sperm production, egg pro-
duction, and fertilization were unaffected. Thus, it istbpN/;
2m/, or tbpN/;
2m/, fetuses were har-
vested after midgestation, and genotypes were deter- almost certain that, despite yielding three live pups,
multiple homozygous fetus/placentas were rejected inmined for both tbp and 
2m. Whereas only 8% of the
tbpN/N fetuses that were 
2m/ survived, 6-fold more these two pregnancies. The results strongly suggest
that individual tbpN/N fetuses can survive in litters in(48%) of the tbpN/N fetuses that were 
2m/ survived
(Table 3). We conclude that the defect in tbpN/N placen- which other tbpN/N fetuses are being resorbed. There-
Cell
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Table 4. Resorbing Fetuses from tbpN/  tbpN/ Matings in Midgestation Litters that Contained Live tbpN/N Fetuses
Genotype Ratios of Live Fetusesa Number of Resorbing Fetuses







Sum of live fetus genotypes 12:20:7
Total fetuses (live  resorbing) 51 fetuses
Estimated zygote genotypesc 13:25:13
Predicted resorbing genotypesd 1:5:6
a Only litters containing tbpN/N fetuses are included, thus inflating representation of tbpN/N fetuses as compared to Table 1. C57BI/6
background, no rescuing mutations.
b Resorbing fetuses could not be genotyped.
c Estimate based on best fit to Mendelian ratio.
d Prediction based on best mathematical fit for the equation: resorbing genotypes 	 estimated zygote genotypes  live fetus genotypes.
fore, survival of individual tbpN/N fetuses is a “trait” of a protein lacking the vertebrate-specific N terminus. Al-
those particular fetuses and not of the mother. Interest- though rare, homozygous adults of both genders are
ingly, since tbpN/N fetuses from tbpN/N parents are healthy and fertile, indicating that this domain of TBP
no more likely to survive than are tbpN/N fetuses from is not required for most vital functions. Nevertheless,
tbpN/ parents (see Supplemental Data), this trait is not 90% of the homozygous mutants died in midgestation
heritable (i.e., not germline genetic). We conclude that from a placental defect. The data indicated that a second
the rejection of tbpN/N fetuses requires both a genetic crisis occurred between late gestation (17.5 d.p.f.) and
component that is dependent on the tbp mutation and weaning, which eliminated about 67% of the remaining
a nonheritable “triggering component” (see Discussion). mutants. Because so few mutants survived the mid-
gestational crisis in normal matings, we have not yet
Rejection of tbpN/N Fetuses Does Not Involve initiated a study of this later crisis point. However, pre-
a Memory Response liminary data from complementation analyses in immu-
If rejection of the tbpN/N fetuses were a classical graft nocompromised mothers suggest that this second crisis
rejection response, it should have a memory compo- is independent of the mother’s immune status. The in-
nent, such that once a mother had rejected a mutant creased midgestational survival obtained by using
fetus, mutants in subsequent pregnancies would be mothers carrying loss-of-function mutations in scid or
more aggressively rejected. Were this the case, all sur- rag1 might provide a system in which we can begin to
viving homozygous animals should have been born to investigate the cause of this second crisis.
mothers that had not previously rejected fetuses. To
test this prediction, we examined the maternal history
of the tbpN/N adults that have survived from natural Evolution of the Basal Transcription Machinery
matings in our colony in the absence of rescuing muta- The chemistry of DNA-dependent RNA polymerization,
tions. Results showed no significant correlation be-
or transcription, has changed little during evolution;
tween homozygote survival and maternal history (see
however, the enzymatic machinery that catalyzes this
Supplemental Data at http://www.cell.com/cgi/content/
process, the basal transcription machinery, shows enor-full/110/1/43/DC1). Only 10 of the 17 pups were from a
mous differences (Figure 3A). As life forms evolvedmother’s first litter. In one exceptional case, a heterozy-
greater complexity, new genes and gene families arosegous mother had four litters, one with a heterozygous
to carry out novel tasks. Concomitantly, new regulatorsmate and three with homozygous mates. Of the 21 pups
were required to restrict transcription of these newweaned, two were homozygous mutants—one in her
genes to specific situations. We posit that the basalfirst litter and one in her fourth—and 17 were heterozy-
transcription machinery coevolved with these targetgotes. Based on our calculation of 70% survival of het-
genes and regulators to facilitate appropriate “situation-erozygotes in these matings (Table 1), during these four
specific” regulation of these novel genetic pathways.pregnancies, she lost roughly 10 tbpN/N and 7 tbpN/
Just like an old computer may lack the ports needed tofetuses, but she still tolerated a tbpN/N fetus in the
communicate with new accessories, the basal transcrip-fourth litter. We conclude that there is no detectable
tion machinery likely needed to acquire new “communi-memory component to the maternal rejection response
cation ports” to participate in advanced gene regulation.on tbpN/N fetuses in syngeneic matings.
We hypothesize that many of the embellishments added
to the basal transcription machinery during evolutionDiscussion
function as specific signaling ports. To test this hypothe-
sis, we removed one such embellishment—the TBP NWe have generated a line of mice in which the endoge-
nous tbp gene was replaced by a version that produces terminus.
The TBP N Terminus
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Figure 3. Models of the Function of the N Terminus of TBP
(A) Evolution’s embellishments on the basal transcription machinery. Model depicts the basal transcription machinery interacting with transcrip-
tional regulators on promoters in archaea and in mammals. The diverse embellishments on the mammalian transcription machinery are posited
to provide novel interaction surfaces that coevolved with the novel transcriptional regulators for advanced situation-specific gene regulation.
(B) Three models of TBP-N-mediated placental gene expression in the maternal/placental interaction. In models 1 and 2, signaling through
the TBP N terminus represses expression of 
2m-dependent antigen presentation, either by directly repressing expression of 
2m (yellow,
model 1) or expression of a MHC-I or MHC-I-like heavy chain (in pink, model 2). The 
2m-dependent antigen presentation is then detected
by an as yet unidentified maternal receptor (light green). In these two models, the regulator (labeled “Reg,” in purple) would be a repressor.
The molecular interaction disrupted by the TBP-N mutation is indicated by a large red “X.” Conversely, in model 3, the regulator may be an
activator, and signaling through the TBP N terminus may induce expression of another target gene (labeled “TG,” in blue), which attenuates,
modifies, or blocks placental 
2m-dependent antigen presentation. This could occur intracellularly, as depicted, or extracellularly, by masking
the 
2m-dependent antigen from the maternal receptor. Points in the process that are affected by the rescuing mutations are indicated as
“
2m/,” “scid/scid,” and “rag1/.”
The N Terminus of TBP as a “Covalent TAF” shown to interact directly with transcription factors or
mediators, whereas others exhibit enzymatic propertiesIn mammals, TBP functions at the core of the multipro-
tein factor TFIID for gene expression (Dynlacht et al., that may only function in specific situations (Albright
and Tjian, 2000). We suspect that many TAFIIs, like the1991; Takada et al., 1992); however, in Archaebacteria,
TBP likely acts alone in its homologous role (Qureshi et N terminus of TBP, arose during evolution as ports or
accessories for advanced genetic processes. Sinceal., 1997). The other components of mammalian TFIID
are proteins known as TBP-associated factors of TFIID, more primitive organisms thrive without these embel-
lishments, one can predict that mice bearing mutationsor TAFIIs (Hernandez, 1993). Several TAFIIs have been
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in late-evolving TAFIIs will generally result in situation- sons we believe that this was a secondary consequence
specific defects (see below), as reported here for the of the placental defect. First, the extent of placental
TBP N terminus. Indeed, we consider the N terminus of histolysis roughly correlated with the degree of develop-
TBP itself to be a TAF, which is covalently linked to TBP mental retardation (data not shown). Second, mutant
as a fusion protein. fetuses having wild-type tetraploid placentas survived
Recently, several tissue-specific components of TFIID (Table 2) and were not developmentally retarded (data
or TFIID-related factors have been genetically disrupted not shown). Finally, most mutant fetuses survive in
in metazoan animals. A screen for male-sterile mutants mothers incapable of mounting a rejection response,
in Drosophila revealed one locus, entitled cannonball, and surviving adults are healthy and fertile. The simplest
that affects spermatogenesis. Positional mapping and explanation for the developmental retardation of N/N
functional analysis indicates that this locus encodes a fetuses is that placental failure compromises develop-
testis-specific TAFII (Hiller et al., 2001). The gene encod- ment of the fetus by causing inefficient nutrient, gas, or
ing the one known mammalian TBP family member, waste exchange with the mother or by otherwise failing
TRF-2, which is most predominantly expressed in testis, to fully support the developing fetus.
has been knocked out in mice and this mutation, too,
leads to male sterility (Zhang et al., 2001). Finally, a
mouse tissue-specific TAFII, TAFII105, has been knocked The N Terminus of TBP Favors Survival
out, leading to a defect in oogenesis and female sterility of Postimplantation Placentas, But Its
(Freiman et al., 2001). All three of these mutations are Function Is Not Likely “Placenta Specific”
in TFIID components that likely evolved in metazoan The tbpN allele was designed on the premise that this
animals, and these mutations, like the tbpN mutation, protein domain serves as a communication port for tran-
have little or no affect on basal functions that are shared scriptional regulation of a process found only in species
with more primitive life forms. In all of these examples, that posses this sequence. Six years ago, when we de-
one might posit that the mutation eliminated a situation- signed and produced these mice, public sequence data
specific signaling port that is only required for highly indicated that tetrapod vertebrates contained the TBP
specialized regulation pathways. Unlike the others, how- N terminus, but lower metazoans, including insects and
ever, the tbpN mutation is the first to disrupt a ubiqui- echinoderms, did not. Therefore, we expected to find a
tously expressed component of TFIID. defect in an “advanced vertebrate-specific characteris-
tic,” such as body form, lungs, adaptations for terrestrial
Placental Consequences of the tbpN Mutation life, etc. The placental defect reported here was not
Previous reports of mutant mice exhibiting placental expected because the TBP N terminus exists in am-
defects can be segregated into those that cause autono- phibia, reptiles, and birds, which generally lack placen-
mous defects in the placenta and those that cause de- tas. We have recently cloned TBP cDNAs from species
fects in how the placenta interacts with the mother. between echinoderms and amphibia, including amphi-
For example, null mutations in the transcription factors oxus, lamprey, shark, and bony fish (A.A.B., K. Daughen-
Mash 2, Ets2, or I-mfa, all of which are required for baugh, M.R.C., and E.E.S., unpublished). These se-
development or function of placental trophoblasts, lead quences indicate that this region of TBP arose and was
to autonomous defects that have been rescued by alter- conserved by natural selection for more than three hun-
ing the placenta (i.e., providing an alternate source of dred million years before the appearance of placental
trophoblast cells), but not by altering the maternal envi- mammals. Why, then, do our mice die from a placental
ronment (Guillemot et al., 1994; Kraut et al., 1998; Ros- defect?
sant et al., 1998; Tanaka et al., 1997; Yamamoto et al., In this paper, we present genetic evidence that remov-
1998). Conversely, disruption of a complement inhibitor,
ing the TBP N terminus disrupts a 
2m-dependent pro-
Crry, leads to an interaction defect between the placenta
cess that the placenta uses to evade a maternal rejection
and the maternal immune system that can be rescued
response. Evidence of
2m-dependent processes, mostby rearing the fetus in mothers incapable of mounting
notably MHC-I presentation, has been found in nearlya normal complement reaction (Xu et al., 2000).
all vertebrate species, but is absent from other life formsGenetic complementation showed that the defect in
(Du Pasquier and Flajnik, 1999). In other experiments, wetbpN/N placentas was an interaction defect rather than
have found that the TBP N terminus may have coevolvedan autonomous defect. In this study, genetic rescue of
with the MHC system, which suggests that it might servemutant fetuses was achieved by two completely differ-
as a signaling port for regulating a subset of MHC activi-ent approaches. In the first, genetic alteration of the
ties (manuscript in preparation). We propose that themother, specifically disrupting V(D)J recombination,
mammalian placenta “coopted” this port, its regulators,provided a maternal environment that allowed survival of
and its target genes to create a genetic mechanism formost mutant fetuses. In the second, second-site genetic
attenuating or evading the maternal immune system inmodification of the zygotic genome, specifically interfer-
this very special situation. The data suggest that ouring with their ability to present MHC-I/MHC-I-like anti-
mice die because, in mammals, this placental role is thegens, caused a 6-fold increase in survival in immune-
first vital function of the pathway. We can rear adultcompetent mothers.
homozygous mutants because, under our care condi-
tions, other functions of this pathway, including thoseThe N Terminus of TBP Is Not Required for Vital
upon which natural selection acted for over three hun-Fetal or Adult Functions
dred million years preceding the appearance of euthe-Prior to resorption, many mutant fetuses showed signs
of developmental retardation; however, for several rea- rian mammals, are not vital.
The TBP N Terminus
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The TBP N Terminus and MHC mother and the fetus/placenta, if any existed, resulted
not from differential gene possession, but rather fromNearly all nucleated cells in the body express MHC-I,
differential gene expression.which plays a key role in host defense against viruses
Most models of immune rejection of pregnancies, for(Pamer and Cresswell, 1998). Above, we proposed that
example in matings between CBA and C57Bl/6 micethe TBP N terminus might be considered a TAF that is
(Munn et al., 1998; Tafuri et al., 1995), are based onlinked as a fusion protein to the TBP C terminus, or in
conditions in which, like in graft rejection, heterogeneityother words, a “covalent TAF.” Of the many TAFs in
at the MHC loci can play a major role in the rejectionmammals, why would natural selection have determined
response. At least one previous study, however, showsthat this one, in particular, should be fused to TBP
that chimeric misexpression of MHC-I transgenes thatC-terminal core? The answer might lie in MHC-I function.
match the mother’s haplotype can lead to placental fail-MHC-I heavy-chain genes, 
2m, and tbp (including the
ure (Jaffe et al., 1992). Because failure occurred in situa-vertebrate-specific N terminus) are among the only “ver-
tions where the transgene and the mother were synge-tebrate-specific genes” that, rather than being ex-
neic, the authors concluded that the mechanisms ofpressed in a tissue-specific fashion, are expressed in
placental failure were not likely immune mediated (Jaffemost cells of the body. Natural selection may have fa-
et al., 1992). By contrast in our study, since tbpN/N fetus/vored fusion of this novel domain to the TBP C-terminal
placentas could be rescued by rearing them in rag1/ orcore because it would ensure that all cells will correctly
scid/scid mothers, maternal immune components veryexpress MHC-I. Conversely, if the TBP N terminus were
likely participated in the rejection response, and a haplo-a separate polypeptide not fused to TBP, intracellular
type-independent immune response should likely be in-pathogens may have more easily evaded MHC-I-medi-
voked in models to explain our results. One intriguingated host defenses by interfering with expression of this
hypothesis that is consistent with many of our observa-TAF while preserving host cell TBP expression. We are
tions is the “danger” model of immunity, in which im-currently beginning studies to determine whether
mune responses can be triggered by endogenous alarmtbpN/N adults exhibit defects in 
2m-dependent pro-
or “distressed cell” signals rather than by nonself anti-cesses, including their susceptibility to intracellular
gen (Matzinger, 2002). Since tbpN/N cells, fetuses, andpathogens.
adults showed no evidence of physiological perturba-Our genetic data are consistent with several mecha-
tions, however, cellular distress in tbpN/N mice wouldnistic models (Figure 3B). In the first and simplest, sig-
likely have to be highly localized to the placenta. Alterna-naling through the TBP N terminus might play a direct
tively, one might invoke a model based on haplotype-role in downregulating 
2m expression in key placental
independent antigens.cells. In a second model, signaling through the TBP N
It is interesting to consider what haplotype-indepen-terminus might play a role in downregulating placental
dent antigens might participate in rejection of the mutantexpression of a MHC-I or a MHC-I-like heavy chain.
placentas. Some endogenous genes encode potentiallyFinally, signaling through the TBP N terminus might play
autoantigenic molecules. Examples include cancer anti-a role in upregulating a placental gene that functions to
gens, immune-sequestered molecules (e.g., nuclearmask or block MHC-I or MHC-I-like molecule presenta-
complexes), and developmentally late appearing mole-tion by the placenta. Ongoing work is aimed at testing
cules (e.g., sperm-specific antigens) (Hall et al., 1994;these three models.
Schreiber, 1999; Shevach, 1999). Some fetal/placental
proteins may also be antigenic due to their normal tis-
Maternal Components of the Rejection Response sue/stage-restricted expression (Wegmann et al., 1979).
Generally, when MHC molecules are implicated in rejec- Moreover, some nonclassical MHC-I genes are likely
tion, haplotype differences play a role in the response expressed only in the placenta, whereas other MHC-I
(Auchincloss et al., 1999). The tbpN mutation was gener- molecules might be strictly repressed in normal placenta
ated on strain 129X1 and was extensively backcrossed (Fuzzi et al., 2002; Hunziker and Wegmann, 1986; Hutter
to strain C57Bl/6, both of which are haplotype b/b. More- et al., 1998; Jaffe et al., 1991; Loke and King, 2000;
over, the tbp gene, and thus the tbpN allele, is tightly Pfeiffer et al., 2001; Riteau et al., 2001). Misregulation
linked to the MHC complex on chromosome 17 (tbp and of these genes could be responsible for failure of the
the MHC also share a common chromosome in humans, mutant placentas. Finally, other possibilities should be
but with a more distant linkage). As such, all mice pre- considered. For example, at least one endogenous ret-
sented in this paper were syngeneic haplotype b/b. Sur- rovirus is known to encode a protein, syncytin, that is
vival to weaning had no gender bias (see Supplemen- required for development of placental giant cells (Mi et
tal Data at http://www.cell.com/cgi/content/full/110/1/ al., 2000). One might consider the possibility that the
43/DC1), excluding a role for sex-linked antigens. In out- TBP N terminus plays a role in activating or repressing
breeding experiments, there was no strain affects in activation of certain germline retroviruses or retroviral
relationship to survival of tbpN/N fetuses (see Supple- genes in the placenta.
mental Data). However, even in these studies, due to Besides occurring in syngeneic conditions, other re-
the tight linkage of tbp and the MHC complex, nearly sults reported here suggest that rejection of tbpN/N
all tbpN/N fetus/placentas were haplotype b/b, and all fetuses by immune-competent mothers is not likely a
mothers, being tbpN/, carried at least one haplotype b classical rejection response. First, we see no evidence
MHC complex. Therefore, none of the tbpN/N fetus/ of memory. Second, rejection of one placenta does not
placentas in this study contained any autosomal loci necessarily compromise other mutant placentas in that
that were also not present, at least in heterozyogous pregnancy, indicating that the maternal response is lo-
calized to individual placentas and suggesting this re-form, in the mother. Antigenic differences between the
Cell
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sponse has no systemic component. Finally, whereas cental component. One simple model might be that the
triggering event is placental hemorrhage. If spontaneousgenetic disruption of 
2m rescued most tbpN/N fetuses,

2m/ tissue grafts are vigorously rejected in a classical hemorrhage occurs naturally and then heals in 90%
of placentas, and this hemorrhage exposes the TBP-rejection response (Li and Faustman, 1993).
rag1/ mice have severely compromised adaptive im- N-dependent defect to the maternal immune system,
it might account for survival of those few tbpN/N fetusesmunity. On the other hand, these mice exhibit relatively
normal levels of innate immune system components, through midgestation. The observation that nongenetic
components can override the genetic predisposition ofincluding NK cells, macrophages, and complement. Be-
cause tbpN//N fetuses were partially rescued by rearing tbpN/N fetuses to maternal immune rejection suggests
that recurrent immune-mediated spontaneous abortionthem in rag1/ mothers, the maternal adaptive immune
system likely played a key role in the failure of tbpN//N in humans might be treated by controlling stochastic
components, rather than the genetic components, of thefetuses in immune-competent mothers. However, be-
cause the adaptive and innate immune systems modu- condition. Using our mouse model system, one might
consider testing whether altering prenatal conditionslate the activities of each other, it is likely that other
maternal factors contribute to the rejection response. could decrease the penetrance of this triggering compo-
nent, and thus increase survival of tbpN/N fetuses.One must consider the possibility that failure of the mu-
tant placentas involves an altered inflammatory re- In summary, we have shown by genetic analyses of
mice lacking the vertebrate-specific TBP N terminussponse, in which the mother’s adaptive immune system
could play a regulatory role, an effector role, or both. that the first critical role for this acquired polypeptide
in mammals is a 
2m-dependent process that helps theNumerous recent studies have implicated both adaptive
and innate immunity in placental tolerance/rejection (re- fetus/placenta evade rejection by the mother’s immune
system. More generally, we posit that this domain canviewed in Erlebacher, 2001), and we consider it likely
that aspects of both innate and adaptive immunity con- be viewed as a covalently linked TAFII that coevolved
with the adaptive immune system to allow regulatedtribute to failure of tbpN/N fetuses.
It is uncertain which components of the adaptive im- production of specific gene products by most cells of
the organism. This, in turn, may potentiate the ability ofmune system are functioning in placental rejection.
Since the effect was highly localized and lacked a de- the immune system to mount an effective and selective
response to certain infectious agents.tectable memory component, it is unlikely that classical
humoral immunity played a pivotal role in the response.
Experimental ProceduresSeveral recently characterized placental immune cells
fit our data as candidate effector cells that could cause
Production of Mice Bearing the tbpN Mutation, Mouse Lines,
rejection of tbpN/N fetuses but would not develop in and Genotyping
SCID or rag1/ mice. One is maternal-derived placental Details of the targeting vector design and mouse production are
presented in the legend to Figure 1 and in the Supplemental DataV14 NKT cells, which respond to an as yet unidentified
at http://www.cell.com/cgi/content/full/110/1/43/DC1. The mousenon-CD1 MHC-I-like 
2m-dependent molecule on the
line involved in this study was produced in 1996 and, except whereplacenta (Dang and Heyborne, 2001). These cells are
noted, data presented are on animals that have been backcrosseddistinct from NKT cells in other maternal organs, which
to C57Bl/6 for 7 generations. C57Bl/6, CD1, and SCID mice were
suggests that they develop de novo in the placenta from Charles River Laboratories. Rag1 and 
2m knockout mice were
(Dang and Heyborne, 2001). Another candidate is mater- from Jackson Labs. All animals were housed in sterile specialized
care facilities. Animal care and all procedures involving live animalsnal V11 T cells, which develop in the placenta and may
were approved by the MSU and/or UU institutional animal care andbe involved in natural abortion (Yamasaki et al., 2001).
use committee(s) and followed established protocols (Hogan et al.,If the immune effector cells involved in rejecting tbpN/N
1994).fetuses developed de novo in each placenta, it may
Genotypes of all mice and fetuses were determined by molecular
explain why survival differs for individual tbpN/N fe- analysis on tail or fetal DNA. The tbpN allele was genotyped as
tuses/placentas within a single litter (Table 4). Moreover, shown in Figure 1. For genotyping the rag1 and 
2m alleles, we
used internally controlled two-primer assays. Primers used for theif these cells were lost with the placenta at birth, it may
rag1 allele were 5-GCT CTA TCG TAA TTC TCA TGA CTG TG-3explain the absence of a memory component to this
and 5-CAA GAG TGA CGG GCA CAG CCG GAG-3. Primers usedrejection response.
for the 
2m allele were 5-CTG AGC TCT GTT TTC GTC TG-3 and
5-AAG TCC ACA CAG ATG GAG CGT-3. The chromosomal locus
TBP N Terminus-Independent Components for each mutant allele in this study is as follows: tbp, chr. 17; scid.
chr. 16; rag1, chr. 2; and 
2m, chr. 2. As such, none of the otherof Placental Failure
mutant alleles are linked to tbp; however, rag and 
2m are linked,Removal of the TBP N terminus genetically predisposed
and tbp is tightly liked to the MHC complex (10 cMorgans).our mice to placental rejection; however, rejection was
only91% penetrant, indicating that an additional “trig-
Diploid/Tetraploid Chimeric Embryo Fusions
gering” component participated in determining whether For diploid embryos, tbpN/ females were induced to super-ovulate
mutant placentas were rejected. Our results indicate and were mated with tbpN/ males. Morulae were harvested 2.5
days later and their zonae were removed (Hogan et al., 1994). Super-that this component is placental, not maternal, and that
ovulated wild-type females were mated to wild-type males on thethis component is not heritable. Based on these obser-
same schedule, and two-celled embryos were harvested at 1.5 d.p.f.vations, it was unlikely that germline-genetic properties
The two-celled wild-type embryos were electro-fused to form one-determined whether mutant placentas were rejected.
celled tetraploid embyros using a BLS CF-150 impulse generator
Instead, we suspect that the triggering component is set at 100V and a square wave pulse of 25 s in 0.3 M mannitol
stochastic. (Guillemot et al., 1994; Nagy et al., 1990). Tetraploid embryos were
cultured overnight to form morulae, and their zonae were removed.It is interesting to speculate about this stochastic pla-
The TBP N Terminus
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Diploid morulae were cocultured overnight with tetraploid morulae. Hogan, B., Beddington, R., Costantini, F., and Lacy, E. (1994). Manip-
ulating the Mouse Embryo: a Laboratory Manual, Second EditionThe next day, blastocyst-stage chimeric embryos were implanted
into pseudo-pregnant wild-type surrogates. (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press).
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